Concepedia

Shigefumi Nakano

SN

Statistics

Publications

7

Citations

391

H-Index

7

Active since

2001

Affiliations

Dokkyo University(Current)

Shigefumi Nakano is an author at Dokkyo University specializing in pharmacology, cardiovascular disease, and cardiology.

Publications per year

2001–2006

7

Publications

7

Cardioprotective Mechanisms of Eplerenone on Cardiac Performance and Remodeling in Failing Rat Hearts

Naohiko Kobayashi, Kohtaro Yoshida, Shigefumi Nakano et al. · Hypertension · 2006 · 111 citations

Medicine, Cardiology, Pharmacology +17

Eplerenone Shows Renoprotective Effect by Reducing LOX-1–Mediated Adhesion Molecule, PKCε-MAPK-p90RSK, and Rho-Kinase Pathway

Naohiko Kobayashi, Kazuyoshi Hara, Akihiro Tojo et al. · Hypertension · 2005 · 97 citations · Full text

Life Sciences, Molecular Medicine, Pharmacology +17

Involvement of Rho-Kinase Pathway for Angiotensin II-Induced Plasminogen Activator Inhibitor-1 Gene Expression and Cardiovascular Remodeling in Hypertensive Rats

Naohiko Kobayashi, Shigefumi Nakano, Shin-ichiro Mita et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 68 citations

Medicine, Cardiology, Pharmacology +16

Critical role of bradykinin-eNOS and oxidative stress-LOX-1 pathway in cardiovascular remodeling under chronic angiotensin-converting enzyme inhibition

Naohiko Kobayashi, Takeaki Honda, Kohtaro Yoshida et al. · Atherosclerosis · 2005 · 36 citations

Life Sciences, Cardiology, Pharmacology +14

Nicorandil Protects Against Lethal Ischemic Ventricular Arrhythmias and Up-regulates Endothelial Nitric Oxide Synthase Expression and Sulfonylurea Receptor 2 mRNA in Conscious Rats with Acute Myocardial Infarction

Shigeo Horinaka, Naohiko Kobayashi, Akihisa Yabe et al. · Cardiovascular Drugs and Therapy · 2004 · 34 citations

Medicine, Cardiology, Pharmacology +15

1–5 of 7